Literature DB >> 9631418

Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression.

K Ohara1, M Nagai, Y Suzuki, K Ohara1.   

Abstract

Several studies have shown that depressed patients have significantly lower catechol-o-methyltransferase (COMT) activity than healthy controls. Two COMT genes coding for low activity, COMTL, and high activity, COMTH have been identified. We undertook an association study on 75 depressive disorder patients, 40 bipolar disorder patients and 135 healthy controls. All the subjects were Japanese. Patients with depressive disorders exhibited a significantly higher rate of genotypes with the COMTL allele than healthy controls (p = 0.012), which was not the case in patients with bipolar disorders. The presence of the COMTL allele was significantly associated with depressive disorders (odds ratio 2.19, 95% CI 1.19-4.03). Our results suggest the COMTL allele contributed to the etiologies of depressive disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631418     DOI: 10.1097/00001756-199805110-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

1.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

Review 2.  Early institutionalization: neurobiological consequences and genetic modifiers.

Authors:  Margaret Sheridan; Stacy Drury; Kate McLaughlin; Alisa Almas
Journal:  Neuropsychol Rev       Date:  2010-11-03       Impact factor: 7.444

3.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

4.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

5.  Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression.

Authors:  Christopher C Conway; Constance Hammen; Patricia A Brennan; Penelope A Lind; Jake M Najman
Journal:  Depress Anxiety       Date:  2010-08       Impact factor: 6.505

6.  COMT Val158Met polymorphism influences the susceptibility to framing in decision-making: OFC-amygdala functional connectivity as a mediator.

Authors:  Xiaoxue Gao; Pingyuan Gong; Jinting Liu; Jie Hu; Yue Li; Hongbo Yu; Xiaoliang Gong; Yang Xiang; Changjun Jiang; Xiaolin Zhou
Journal:  Hum Brain Mapp       Date:  2016-02-25       Impact factor: 5.038

7.  Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen.

Authors:  Chih-Chuan Pan; Douglas R McQuoid; Warren D Taylor; Martha E Payne; Allison Ashley-Koch; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

8.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

9.  No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders.

Authors:  Gil Zalsman; Yung-yu Huang; Maria A Oquendo; David A Brent; Lucas Giner; Fatemeh Haghighi; Ainsley K Burke; Steven P Ellis; Dianne Currier; J John Mann
Journal:  Arch Suicide Res       Date:  2008

10.  Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults.

Authors:  Karin F Hoth; Robert H Paul; Leanne M Williams; Carol Dobson-Stone; Elizabeth Todd; Peter R Schofield; John Gunstad; Ronald A Cohen; Evian Gordon
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.